Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/23822
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShah, A-
dc.contributor.authorKishore, U-
dc.contributor.authorShastri, A-
dc.date.accessioned2021-12-26T08:40:37Z-
dc.date.available2021-12-26T08:40:37Z-
dc.date.issued2021-12-20-
dc.identifier13647-
dc.identifier.citationShah, A., Kishore, U. and Shastri, A. (2021) ‘Complement System in Alzheimer’s Disease’, International Journal of Molecular Sciences, 22(24), 13647, pp. 1-21. doi: 10.3390/ijms222413647.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/23822-
dc.description.abstractCopyright: © 2021 by the authors. Alzheimer’s disease is a type of dementia characterized by problems with short-term memory, cognition, and difficulties with activities of daily living. It is a progressive, neurodegenerative disorder. The complement system is an ancient part of the innate immune system and comprises of more than thirty serum and membrane-bound proteins. This system has three different activating pathways and culminates into the formation of a membrane attack complex that ultimately causes target cell lysis (usually pathogens) The complement system is involved in several important functions in the central nervous system (CNS) that include neurogenesis, synaptic pruning, apoptosis, and neuronal plasticity. Here, we discuss how the complement system is involved in the effective functioning of CNS, while also contributing to chronic neuroinflammation leading to neurodegenerative disorders such as Alzheimer’s disease. We also discuss potential targets in the complement system for stopping its harmful effects via neuroinflammation and provide perspective for the direction of future research in this field.en_US
dc.format.extent1 - 21-
dc.format.mediumElectronic-
dc.language.isoen_USen_US
dc.publisherMDPI AGen_US
dc.rightsCopyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectAlzheimer’s diseaseen_US
dc.subjectcomplement systemen_US
dc.subjectmicrogliaen_US
dc.titleComplement System in Alzheimer's Diseaseen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.3390/ijms222413647-
dc.relation.isPartOfInternational Journal of Molecular Sciences-
pubs.publication-statusPublished online-
pubs.volume22-
dc.identifier.eissn1422-0067-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.59 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons